← Back to all trials
Not Yet Recruiting
NCT05601492
Adherence to Otezla
Conditions: Psoriasis
Sex: All
Ages: 18 Years – 85 Years
Phase: EARLY_PHASE1
Enrollment: 84
Sponsor: Wake Forest University Health Sciences
Location: United States
Summary
Most people with psoriasis have very limited disease, yet that disease may still have a large impact on their lives.
While limited psoriasis may be amenable to topical treatment, patients are exceptionally poorly adherent to topical treatment, especially over the long run.
Eligibility Criteria
Inclusion Criteria:Adult 18 years or olderDiagnosis of mild psoriasis with Otezla recommendationNon-pregnantEnglish speakingExclusion Criteria:Under 18 years of ageNot diagnosis of mild psoriasisPregnantNon-English speaking
Source: ClinicalTrials.gov (NCT05601492). StuddyBuddy aggregates publicly available trial information.
